Caffeine induction of sulfotransferases in rat liver and intestine

Journal of Applied Toxicology

Volumn 32, Issue 10, 2012, Pages 804-809

  Zhou, Tianyan ^a,b   Chen, Yue ^b   Huang, Chaoqun ^b   Chen, Guangping ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Caffeine; Induction; Regulation; Sulfotransferase; SULT1A1; SULT2A1

Indexed keywords

ARYL SULFOTRANSFERASE; CAFFEINE; HYDROXYSTEROID SULFOTRANSFERASE; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DOSE RESPONSE; DRUG METABOLISM; ENZYME INDUCTION; ENZYME REGULATION; FEMALE; HORMONE RELEASE; INTESTINE; INTESTINE CELL; INTESTINE MUCOSA; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TISSUE LEVEL; WESTERN BLOTTING;

ANIMALS; ARYLSULFOTRANSFERASE; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; ENZYME INDUCTION; FEMALE; FOOD-DRUG INTERACTIONS; INTESTINAL MUCOSA; INTESTINE, SMALL; LIVER; MALE; ORGAN SPECIFICITY; PHOSPHODIESTERASE INHIBITORS; PURINERGIC P1 RECEPTOR ANTAGONISTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEX CHARACTERISTICS; SULFOTRANSFERASES;

RATTUS;

EID: 84865825084     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1698     Document Type: Article

References (46)

1. Bhaskara S, Dean ED, Lam V, Ganguly R. 2006. Induction of two cytochrome P450 genes, Cyp6a2 and Cyp6a8, of Drosophila melanogaster by caffeine in adult flies and in cell culture. Gene 377: 56-64.
2. Bhaskara S, Chandrasekharan MB, Ganguly R. 2008. Caffeine induction of Cyp6a2 and Cyp6a8 genes of Drosophila melanogaster is modulated by cAMP and D-JUN protein levels. Gene 415(1-2): 49-59.
3. Chapman E, Best MD, Hanson SR, Wong CH. 2004. Sulfotransferases: structure, mechanism, biological activity, inhibition, and synthetic utility. Angew. Chem. Int. Edn Engl. 43(27): 3526-3548.
4. Chen JF, Yu L, Shen HY, He JC, Wang X, Zheng R. 2010a. What knock-out animals tell us about the effects of caffeine. J. Alzheimers Dis. 20(suppl. 1): S17-24.
5. Chen X, Baker SM, Chen G. 2005. Methotrexate induction of human sulfotransferases in Hep G2 and Caco-2 cells. J. Appl. Toxicol. 25: 354-360.
6. Chen X, Maiti S, Zhang J, Chen G. 2006. Nuclear receptor interactions in methotrexate induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1). J. Biochem. Mol. Toxicol. 20(6): 309-317.
7. Chen X, Zhang J, Baker SM, Chen G. 2007. Human constitutive androstane receptor mediated methotrexate induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1). Toxicology 231(2-3): 224-233.
8. Chen Y, Huang C, Zhou T, Chen G. 2008. Genistein induction of human sulfotransferases in HepG2 and Caco-2 cells. Basic Clin. Pharmacol. Toxicol. 103(6): 553-559.
9. Chen Y, Huang C, Zhou T, Zhang S, Chen G. 2010b. Biochanin A induction of sulfotransferases in rats. J. Biochem. Mol. Toxicol. 24(2): 102-114.
10. Colas C, James P, Howes L, Jones R, Cebrian-Perez JA, Muino-Blanco T. 2008. Cyclic-AMP initiates protein tyrosine phosphorylation independent of cholesterol efflux during ram sperm capacitation. Reprod. Fertil. Devl. 20(6): 649-658.
11. Coughtrie MW. 2002. Sulfation through the looking glass - recent advances in sulfotransferase research for the curious. Pharmacogenom. J. 2(5): 297-308.
12. Crain SM, Shen KF. 2008. Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naive mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone. Brain Res. 1231: 16-24.
13. Dutta SM, Maiti S, Chen G. 2008. Effect of folic acid on methotrexate induction of sulfotransferases in rats. Drug Metab. Lett. 2(2): 115-119.
14. Gamage N, Barnett A, Hempel N, Duggleby RG, Windmill KF, Martin JL, McManus ME. 2006. Human sulfotransferases and their role in chemical metabolism. Toxicol. Sci. 90(1): 5-22.
15. Glatt H, Meinl W. 2004. Pharmacogenetics of soluble sulfotransferases (SULTs). Naunyn Schmiedeberg's Arch. Pharmacol. 369(1): 55-68.
16. Glatt H, Engelke CE, Pabel U, Teubner W, Jones AL, Coughtrie MW, Andrae U, Falany CN, Meinl W. 2000. Sulfotransferases: genetics and role in toxicology. Toxicol. Lett. 112-113: 341-348.
17. Goasduff T, Dreano Y, Guillois B, Menez JF, Berthou F. 1996. Induction of liver and kidney CYP1A1/1A2 by caffeine in rat. Biochem. Pharmacol. 52(12): 1915-1919.
18. Hochberg Z, Hertz P, Benderly A. 1984. Caffeine stimulates growth hormone secretion by cultured rat pituitary cells. J. Endocrinol. Invest. 7(1): 59-60.
19. Jones G. 2008. Caffeine and other sympathomimetic stimulants: modes of action and effects on sports performance. Essays Biochem. 44: 109-123.
20. Klaassen CD, Liu L, Dunn RT. 1998. Regulation of sulfotransferase mRNA expression in male and female rats of various ages. Chemico-Biol. Interact. 109(1-3): 299-313.
21. Kot M, Daniel WA. 2008a. Caffeine as a marker substrate for testing cytochrome P450 activity in human and rat. Pharmacol. Rep. 60(6): 789-797.
22. Kot M, Daniel WA. 2008b. The relative contribution of human cytochrome P450 isoforms to the four caffeine oxidation pathways: an in vitro comparative study with cDNA-expressed P450s including CYP2C isoforms. Biochem. Pharmacol. 76(4): 543-551.
23. Kot M, Daniel WA. 2008c. Relative contribution of rat cytochrome P450 isoforms to the metabolism of caffeine: the pathway and concentration dependence. Biochem. Pharmacol. 75(7): 1538-1549.
24. Kotsopoulos J, Ghadirian P, El-Sohemy A, Lynch HT, Snyder C, Daly M, Domchek S, Randall S, Karlan B, Zhang P, Zhang S, Sun P, Narod SA. 2007. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol. Biomark. Prev. 16(5): 912-916.
25. Kotsopoulos J, Vitonis AF, Terry KL, De Vivo I, Cramer DW, Hankinson SE, Tworoger SS. 2009. Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer. Cancer Causes Control 20(3): 335-344.
26. Liu L, Klaassen CD. 1996a. Ontogeny and hormonal basis of male-dominant rat hepatic sulfotransferases. Mol. Pharmacol. 50(3): 565-572.
27. Liu L, Klaassen CD. 1996b. Regulation of hepatic sulfotransferases by steroidal chemicals in rats. Drug Metab. Dispos. 24(8): 854-858.
28. Liu L, LeCluyse EL, Liu J, Klaasen CD. 1996. Sulfotransferase gene expression in primary cultures of rat hepatocytes. Biochem. Pharmacol. 52(10): 1621-1630.
29. Maiti S, Chen G. 2003. Methotrexate is a novel inducer of rat liver and intestinal sulfotransferases. Arch. Biochem. Biophys. 418(2): 161-168.
30. Maiti S, Chen X, Chen G. 2005. All-trans retinoic acid induction of sulfotransferases. Basic Clin. Pharmacol. Toxicol. 96(1): 44-53.
31. Morelli M, Carta AR, Kachroo A, Schwarzschild MA. 2010. Pathophysiological roles for purines: adenosine, caffeine and urate. Prog. Brain Res. 183: 183-208.
32. Murosaki S, Lee TR, Muroyama K, Shin ES, Cho SY, Yamamoto Y, Lee SJ. 2007. A combination of caffeine, arginine, soy isoflavones, and l-carnitine enhances both lipolysis and fatty acid oxidation in 3T3-L1 and HepG2 cells in vitro and in KK mice in vivo. J. Nutr. 137(10): 2252-2257.
33. Nimmagadda D, Cherala G, Ghatta S. 2006. Cytosolic sulfotransferases. Indian J. Exp. Biol. 44(3): 171-182.
34. Pacifici GM. 2004. Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: a review of the literature. Int. J. Clin. Pharmacol. Ther. 42(9): 488-495.
35. Patz MD, Day HE, Burow A, Campeau S. 2006. Modulation of the hypothalamo-pituitary-adrenocortical axis by caffeine. Psychoneuroendocrinology 31(4): 493-500.
36. Prediger RD. 2010. Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms. J. Alzheimers Dis. 20(suppl. 1): S205-220.
37. Riddoch FC, Brown AM, Rowbotham SE, Redfern CP, Cheek TR. 2007. Changes in functional properties of the caffeine-sensitive Ca2+ store during differentiation of human SH-SY5Y neuroblastoma cells. Cell Calcium 41(3): 195-206.
38. Runge-Morris MA. 1997. Regulation of expression of the rodent cytosolic sulfotransferases. FASEB J. 11(2): 109-117.
39. Runge-Morris M, Kocarek TA. 2005. Regulation of sulfotransferases by xenobiotic receptors. Curr. Drug Metab. 6(4): 299-307.
40. Runge-Morris M, Kocarek TA. 2009. Regulation of sulfotransferase and UDP-glucuronosyltransferase gene expression by the PPARs. PPAR Res. 2009: 728941.
41. Shapiro RE. 2007. Caffeine and headaches. Neurol. Sci. 28(suppl. 2): S179-183.
42. Suzuki T, Miki Y, Nakamura Y, Ito K, Sasano H. 2010. Steroid sulfatase and estrogen sulfotransferase in human carcinomas. Mol. Cell Endocrinol. doi:10.1016/j.mce.2010.11.001
43. Welsch CW. 1994. Caffeine and the development of the normal and neoplastic mammary gland. Proc. Soc. Exp. Biol. Med. 207(1): 1-12.
44. Welsch CW, VanderPloeg LC. 1994. Enhancement by caffeine of mammary gland lobulo-alveolar development in mice: a function of increased corticosterone. J. Environ. Pathol. Toxicol. Oncol. 13(2): 81-88.
45. Yang A, Palmer AA, de Wit H. 2010. Genetics of caffeine consumption and responses to caffeine. Psychopharmacology 211(3): 245-257.
46. Zhou TY, Huang CQ, Chen Y, Shanbag P, Chen GP. 2010. Methamphetamine regulation of sulfotransferases in rat liver and brain. Am. J. Pharmacol. Toxicol. 5(3): 125-132.